4 citations
,
March 2021 in “International Journal of Environmental Research and Public Health” This preliminary case-control study investigated body composition and skinfold thickness differences between women with polycystic ovary syndrome (PCOS) and those without, involving 266 women, 117 of whom were diagnosed with PCOS using the Rotterdam criteria. The study found that women with PCOS had a higher body mass index, fat mass percentage, and endomorphy component compared to controls. Each PCOS phenotype showed distinct somatochart representations, with the H-O-POM phenotype exhibiting significantly higher skinfold thicknesses and fat mass percentage than controls. These findings suggested that body composition differences in women with PCOS, particularly in the H-O-POM phenotype, could impact clinical evaluation and follow-up, highlighting the need for further research.
4 citations
,
June 2021 in “Applied Sciences” This study investigated the body composition differences between women with PCOS and those without, using anthropometric methods, and examined their potential as predictors of insulin resistance (IR) and lipid profile (LP). The study included 126 women with PCOS and 159 controls. Women with PCOS exhibited higher body mass index, fat mass percentage, and testosterone levels. Fat mass was linked to higher triglycerides and LDL-c, and lower HDL-c, regardless of PCOS status. HOMA-IR was more significant in PCOS patients and related to fat mass. Higher bone mass correlated with lower cholesterol levels, independent of PCOS. Lean mass predicted a better metabolic profile, influenced by PCOS. The study emphasized the role of body composition in PCOS and its association with a poorer metabolic profile, with PCOS linked to worse HOMA-IR independent of body composition.
May 2017 in “Endocrine Abstracts” Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.
37 citations
,
June 2011 in “Journal of Cellular Biochemistry” Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.
July 2023 in “The Journal of Clinical Endocrinology and Metabolism” Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.